621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC).
Saved in:
| Title: | 621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC). |
|---|---|
| Authors: | Modi, S.1 (AUTHOR), Ates, O.2 (AUTHOR), Baird, R.D.3 (AUTHOR), Bulat, I.V.4 (AUTHOR), Moreno Candilejo, I.5 (AUTHOR), Curigliano, G.6 (AUTHOR), Dalenc, F.7 (AUTHOR), Jerzak, K.8 (AUTHOR), Maglakelidze, M.9 (AUTHOR), Savas, P.10 (AUTHOR), Wenger, M.11 (AUTHOR), Brück, P.11 (AUTHOR), Munshi, N.12 (AUTHOR), Guo, Z.13 (AUTHOR), Qiu, Y.14 (AUTHOR), Mu, H.14 (AUTHOR), Türeci, Ö.15 (AUTHOR), Sahin, U.16 (AUTHOR), Shao, Z-M.17 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS465-S465. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1043 |
